Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
100Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $18.02B | $2.29B | $4.07 |
| 2024 | $17.49B | $1.97B | $3.44 |
| 2023 | $15.16B | $13.22B | $3.75 |
| 2022 | $13.80B | $3.23B | $4.63 |
| 2021 | $12.93B | $2.30B | $3.85 |
Social Signal Score
Earnings
Wed, Nov 4(in 3 months)
Consensus estimate $1.83 per share
Typical surprise +1.8% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Aug 4$1.71 vs $1.68beat
- Tue, May 5$1.54 vs $1.53beat
- Tue, Feb 3$1.46 vs $1.42beat
- Wed, Nov 5$1.62 vs $1.62beat
- Wed, Aug 6$1.52 vs $1.51beat
- Wed, May 7$1.48 vs $1.41beat
Estimates and results for EMR via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
Project earnings forward and see what return today's price implies.
Seeded from EMR's reported EPS growth of 1.4% a year over 4 years.
- EPS in 5 years
- $4.37
- Implied price
- $139.76
- Return from $163.13
- -3.0% a year
To earn 15.0% a year on these assumptions you'd need to buy at $69.49 — -57.4% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 22 | 27 | 32 | 37 | 42 |
|---|---|---|---|---|---|
| -8.6% | -18.9% | -15.5% | -12.6% | -10.0% | -7.7% |
| -3.6% | -14.5% | -10.9% | -7.8% | -5.1% | -2.7% |
| 1.4% | -10.0% | -6.3% | -3.0% | -0.2% | 2.4% |
| 6.4% | -5.6% | -1.7% | 1.7% | 4.7% | 7.4% |
| 11.4% | -1.2% | 3.0% | 6.5% | 9.7% | 12.5% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Mentions (1)
- Newsprnewswire.com·2d ago·Neutral
Emerson to Automate BP-Operated Shah Deniz Compression Project Integrated control and safety systems will support remote operations, improving safety, reliability and production on a normally unattended offshore platform BP extends collaboration with Emerson to maximize gas recovery and processing efficiency. Integrated control and safety systems provide process control, safety shutdown, fire and gas detection, and power management.
View source ↗